Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[What makes bacteria pathogenic?].

L H Vorland1

  • 1Mikrobiologisk avdeling Regionsykehuset i Tromsø 9038 Tromsø. lars.vorland@rito.no

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|January 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chlamydia pneumoniae IgA- and IgG antibodies in young survivors of myocardial infarction. A comparison of antibody detection by a microimmunofluorescence test and an enzyme immunoassay.

Journal of internal medicine·2002
Same author

[Natural antimicrobial peptides--promising new antibiotics or a problem later on?].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2002
Same author

The antimicrobial peptides lactoferricin B and magainin 2 cross over the bacterial cytoplasmic membrane and reside in the cytoplasm.

FEBS letters·2001
Same author

Remarkable attachment of lactoferrin to Streptococcus pyogenes during acute pharyngotonsillitis.

Acta oto-laryngologica·2001
Same author

Post-antibiotic effect of the antimicrobial peptide lactoferricin on Escherichia coli and Staphylococcus aureus.

The Journal of antimicrobial chemotherapy·2001
Same author

Bactericidal kinetics of 3 lactoferricins against Staphylococcus aureus and Escherichia coli.

Scandinavian journal of infectious diseases·2001

Pathogens cause disease by evading host defenses and damaging cells. Understanding bacterial virulence factors and host immune responses is key to combating infections.

Area of Science:

  • Microbiology
  • Immunology
  • Pathogenesis

Context:

  • Host-pathogen interactions are complex, with outcomes depending on both microbial properties and host defenses.
  • The human body possesses overlapping non-specific (e.g., phagocytes, complement) and specific (e.g., antibodies, cytotoxic cells) immune defenses against microbial invasion.

Purpose:

  • To explore the mechanisms by which certain microorganisms achieve pathogenicity.
  • To elucidate how bacterial virulence factors enable pathogens to evade host defenses and cause disease.

Summary:

  • Pathogenicity involves microbial specialization for replication within hosts and subsequent damage.
  • Bacteria employ strategies like adherence, invasion, and toxin production to overcome host defenses.
  • Virulence factor production is a regulated process crucial for successful infection.

Related Experiment Videos

Impact:

  • Highlights the critical role of non-specific defenses in early infection stages.
  • Emphasizes the evolutionary arms race between pathogens and host immune systems.
  • Provides insights into microbial strategies for evading immune surveillance and causing disease.